CIK 0001087294
- Non-accelerated filer
- Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- Operating
- EIN
- 621765329
- Phone
- +1 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Financial Officer bought 400 shares at an average $6.00 ($2,400)
- 4 Gift Chairman and CEO gave 200,000 shares (gift)
- 4 Open-market buy Chief Financial Officer bought 400 shares at $6.12 ($2,448)
- 4 Grant or award Sr VP/Chief Commercial Officer acquired 5,000 shares (grant or award)
- 4 Grant or award SVP and Chief Development Off. acquired 25,000 shares (grant or award)
- 4 Grant or award VP and Chief Compliance Office acquired 3,000 shares (grant or award)
- 4 Grant or award Chairman and CEO acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Open-market buy Chief Financial Officer bought 300 shares at $6.72 ($2,016)
- 4 Gift Chairman and CEO gave 15,000 shares (gift)
- 4 Open-market buy Director bought 3,300 shares at $7.55 ($24,915)
- 4 Open-market buy Chief Financial Officer bought 250 shares at $7.81 ($1,953)
- 4 Open-market buy Chief Financial Officer bought 500 shares at $6.72 ($3,360)
Page 17 of 26 · 512 filings